Mycobacterium tuberculosis Beijing Type Mutation Frequency

Por Werngren, Jim
Publicado em 2013

Drug-Susceptible Mycobacterium tuberculosis Beijing Genotype Does Not Develop Mutation-Conferred Resistance to Rifampin at an Elevated Rate

Por Werngren, Jim, Hoffner, Sven E.
Publicado em 2003

Evaluation of a Novel Kit for Use with the BacT/ALERT 3D System for Drug Susceptibility Testing of Mycobacterium tuberculosis

Por Werngren, Jim, Klintz, Lisbeth, Hoffner, Sven E.
Publicado em 2006

Resistance Levels and rpoB Gene Mutations among In Vitro-Selected Rifampin-Resistant Mycobacterium tuberculosis Mutants

Por Huitric, Emma, Werngren, Jim, Juréen, Pontus, Hoffner, Sven
Publicado em 2006

Pyrazinamide Resistance and pncA Gene Mutations in Mycobacterium tuberculosis

Por Juréen, Pontus, Werngren, Jim, Toro, Juan-Carlos, Hoffner, Sven
Publicado em 2008

Dynamics of Antibiotic Resistant Mycobacterium tuberculosis during Long-Term Infection and Antibiotic Treatment

Por Mariam, Solomon H., Werngren, Jim, Aronsson, Joakim, Hoffner, Sven, Andersson, Dan I.
Publicado em 2011

Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatment

Por Hu, Yi, Zhao, Qi, Werngren, Jim, Hoffner, Sven, Diwan, Vinod K., Xu, Biao
Publicado no BMC Infect Dis (2016)

In Vitro Activity of AZD5847 against Geographically Diverse Clinical Isolates of Mycobacterium tuberculosis

Por Werngren, Jim, Wijkander, Maria, Perskvist, Nasrin, Balasubramanian, V., Sambandamurthy, Vasan K., Rodrigues, Camilla, Hoffner, Sven
Publicado em 2014

Evaluation of a microcolony growth monitoring method for the rapid determination of ethambutol resistance in Mycobacterium tuberculosis

Por den Hertog, Alice L, Menting, Sandra, Smienk, Ernst T, Werngren, Jim, Hoffner, Sven, Anthony, Richard M
Publicado no BMC Infect Dis (2014)

Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China

Por Li, Dange, Hu, Yi, Werngren, Jim, Mansjö, Mikael, Zheng, Xubin, Drobniewski, Francis, Hoffner, Sven, Xu, Biao
Publicado no Antimicrob Agents Chemother (2016)

Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China

Por Zheng, Xubin, Zheng, Rongrong, Hu, Yi, Werngren, Jim, Forsman, Lina Davies, Mansjö, Mikael, Xu, Biao, Hoffner, Sven
Publicado no Antimicrob Agents Chemother (2016)

Can Molecular Methods Detect 1% Isoniazid Resistance in Mycobacterium tuberculosis?

Por Folkvardsen, Dorte Bek, Svensson, Erik, Thomsen, Vibeke Ø., Rasmussen, Erik Michael, Bang, Didi, Werngren, Jim, Hoffner, Sven, Hillemann, Doris, Rigouts, Leen
Publicado em 2013

Resistance to First-Line Anti-TB Drugs Is Associated with Reduced Nitric Oxide Susceptibility in Mycobacterium tuberculosis

Por Idh, Jonna, Mekonnen, Mekidim, Abate, Ebba, Wedajo, Wassihun, Werngren, Jim, Ängeby, Kristian, Lerm, Maria, Elias, Daniel, Sundqvist, Tommy, Aseffa, Abraham, Stendahl, Olle, Schön, Thomas
Publicado em 2012

A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic setting

Por Wedajo, Wassihun, Schön, Thomas, Bedru, Ahmed, Kiros, Teklu, Hailu, Elena, Mebrahtu, Tesfamariam, Yamuah, Lawrence, Ängeby, Kristian, Werngren, Jim, Onyebujoh, Philip, Dagne, Kifle, Aseffa, Abraham
Publicado no BMC Res Notes (2014)

Rifampin Heteroresistance in Mycobacterium tuberculosis Cultures as Detected by Phenotypic and Genotypic Drug Susceptibility Test Methods

Por Folkvardsen, Dorte Bek, Thomsen, Vibeke Ø., Rigouts, Leen, Rasmussen, Erik Michael, Bang, Didi, Bernaerts, Gertjan, Werngren, Jim, Toro, Juan Carlos, Hoffner, Sven, Hillemann, Doris, Svensson, Erik
Publicado em 2013

Antigen 85C Inhibition Restricts Mycobacterium tuberculosis Growth through Disruption of Cord Factor Biosynthesis

Por Warrier, Thulasi, Tropis, Marielle, Werngren, Jim, Diehl, Anne, Gengenbacher, Martin, Schlegel, Brigitte, Schade, Markus, Oschkinat, Hartmut, Daffe, Mamadou, Hoffner, Sven, Eddine, Ali Nasser, Kaufmann, Stefan H. E.
Publicado em 2012

Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study

Por Miotto, Paolo, Cabibbe, Andrea M., Feuerriegel, Silke, Casali, Nicola, Drobniewski, Francis, Rodionova, Yulia, Bakonyte, Daiva, Stakenas, Petras, Pimkina, Edita, Augustynowicz-Kopeć, Ewa, Degano, Massimo, Ambrosi, Alessandro, Hoffner, Sven, Mansjö, Mikael, Werngren, Jim, Rüsch-Gerdes, Sabine, Niemann, Stefan, Cirillo, Daniela M.
Publicado em 2014

Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of Tuberculosis

Por P, Shahul Hameed, Solapure, Suresh, Mukherjee, Kakoli, Nandi, Vrinda, Waterson, David, Shandil, Radha, Balganesh, Meenakshi, Sambandamurthy, Vasan K., Raichurkar, Anand Kumar, Deshpande, Abhijeet, Ghosh, Anirban, Awasthy, Disha, Shanbhag, Gajanan, Sheikh, Gulebahar, McMiken, Helen, Puttur, Jayashree, Reddy, Jitendar, Werngren, Jim, Read, Jon, Kumar, Mahesh, R, Manjunatha, Chinnapattu, Murugan, Madhavapeddi, Prashanti, Manjrekar, Praveena, Basu, Reetobrata, Gaonkar, Sheshagiri, Sharma, Sreevalli, Hoffner, Sven, Humnabadkar, Vaishali, Subbulakshmi, Venkita, Panduga, Vijender
Publicado em 2014

Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship and In Vivo Efficacy in a Mouse Model of Tuberculosis

Por P, Shahul Hameed, Solapure, Suresh, Mukherjee, Kakoli, Nandi, Vrinda, Waterson, David, Shandil, Radha, Balganesh, Meenakshi, Sambandamurthy, Vasan K., Raichurkar, Anand Kumar, Deshpande, Abhijeet, Ghosh, Anirban, Awasthy, Disha, Shanbhag, Gajanan, Sheikh, Gulebahar, McMiken, Helen, Puttur, Jayashree, Reddy, Jitendar, Werngren, Jim, Read, Jon, Kumar, Mahesh, R, Manjunatha, Chinnapattu, Murugan, Madhavapeddi, Prashanti, Manjrekar, Praveena, Basu, Reetobrata, Gaonkar, Sheshagiri, Sharma, Sreevalli, Hoffner, Sven, Humnabadkar, Vaishali, Subbulakshmi, Venkita, Panduga, Vijender
Publicado em 2014